Next-generation drug from Eli Lilly boosts weight loss to 24% ... - CNN
网页2023年6月26日 · An experimental drug from Eli Lilly helped patients with obesity lose an average of 24% of their body weight over 48 weeks on the highest dose in a mid-stage study, the most weight loss seen...
What the results of Wegovy’s longest clinical trial yet show about ...
网页2024年5月13日 · Weight loss continued for more than a year. The analysis showed an average weight loss of just over 10% for people who used semaglutide, the active ingredient in Wegovy, compared with 1.5%...
FDA approves Eli Lilly’s Zepbound, a weight loss drug ... - NBC News
网页2023年11月8日 · The Food and Drug Administration on Wednesday approved Zepbound, a new weight loss drug from drugmaker Eli Lilly that was shown in clinical trials to help people lose up to 52 pounds in 16 months.
What to Know About Zepbound, the New Weight Loss Drug - The New York Times
网页2023年11月8日 · The decision by the Food and Drug Administration on Wednesday to approve the weight loss drug tirzepatide adds a potent new tool to the fast-growing arsenal of obesity drugs.
Beyond Ozempic: New GLP-1 drugs promise weight loss and …
网页On Thursday, ahead of the diabetes conference, Denmark-based biotech firm Zealand Pharma released data that showed a high dose of its experimental weight loss drug petrelintide helped reduce body...
Zepbound outperforms Ozempic and Wegovy in head-to-head weight loss …
网页2024年7月8日 · Since Zepbound was approved for weight loss in late 2023, it appeared to have an advantage over Wegovy. Patients taking the highest dose of Zepbound lost around 21% of their body weight over...
Where Ozempic, Wegovy and New Weight Loss Drugs Came …
网页2023年8月17日 · What to Know: How do Ozempic and other drugs used for weight loss work? Here’s a primer. What Happens if You Stop?: Many patients are eager to discontinue the drugs when their weight loss...
FDA approves Wegovy, a new drug to fight obesity - CBS News
网页2021年6月10日 · The FDA on Friday approved a new weight-loss drug, Wegovy, for people who are either obese or overweight and have at least one weight-related medical problem.
F.D.A. Approves New Obesity Drug That Will Compete With Wegovy
网页2023年11月8日 · Patients who used tirzepatide lost an average of 18 percent of their body weight, according to the F.D.A., when it was taken at its highest dose in a drug trial. That’s compared with Wegovy,...
Weight-loss drug Wegovy produces ‘largest benefit ever seen’ for ...
网页2023年8月25日 · A study found that a 2.4-milligram weekly dose of semaglutide, sold as Wegovy for weight loss, led to an improvement of 17 points on a 100-point scale that’s used to assess symptoms of a ...